Biotech outfit Neuren rattles tin for equity via Bell Potter
MELBOURNE: Bankers for clinical-stage biotech company Neuren Pharmaceuticals will be pounding the virtual pavement on
MELBOURNE: Bankers for clinical-stage biotech company Neuren Pharmaceuticals will be pounding the virtual pavement on